Dr Thibault Renoir
PhD, PharmD

Following his doctorate degree in pharmacy (PharmD, 2005), Dr Renoir obtained his PhD in 2009. This early work was carried out at the University of Paris 6 (INSERM, France) and supervised by Drs L Lanfumey and M Hamon. Dr Renoir joined Professor Hannan’s group at The Florey in 2009 and has been leading his independent group as Senior Florey Research Fellow since 2017.

Dr Renoir’s research group examines the mechanisms by which gene-environment interactions influence neurodegenerative (e.g. Huntington’s disease and other dementias) and psychiatric disorders (e.g. depression, anxiety, schizophrenia and OCD). His current research aims to understand how environmental and lifestyle factors such as stress, directly and indirectly, impact behaviour, cognition and physiology via dynamic molecular/cellular changes in the brain. Along with exploring the mechanisms driving the beneficial effects of physical exercise, this research aims to identify new targets for future therapies.

Since his move to Australia, Dr Renoir has been awarded 3 fellowships (2014–16 ARC DECRA, 2017–2021 NHMRC Boosting Dementia Research Leadership Fellowship, 2022–2025 Ronald Philip Griffths Fellowship). Overall, Dr Renoir’s work has attracted $3.2+ million in highly competitive funding (including 3 NHMRC Project Grants).